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Abstract 
The goal of universal health coverage is to “ensure that all people obtain the health services they need 
without suffering financial hardship when paying for them.” There are many connections between this 
goal and the state’s legal obligation to realize the human right to health. In the context of this goal, 
it is important to assess private actors’ involvement in the health sector. For example, private actors 
may not always have the incentives to deal with externalities that affect the availability, accessibility, 
acceptability, and quality of health care services; they may not be in a position to provide “public goods”; 
or they may operate under imperfect information. This paper sets out to answer the question, what legal 
human rights obligations do states have in terms of regulating private sector involvement in health care?
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Introduction
There are many connections between the goal of 
universal health coverage (UHC) and the state’s 
legal obligation to realize the human right to the 
highest attainable standard of health. The right-to-
health framework provides a set of legally binding 
standards directing the state to ensure the avail-
ability, accessibility, acceptability, and quality of 
all health-related services for everyone residing on 
its territory.1 
This article focuses on the role of the private 
sector in the direct provision of health care, the 
supply of health care-related goods, and health 
care financing. Private sector involvement in the 
provision of health care encompasses a complex 
range of activities carried out by various non-state 
actors. These actors may include (multi)national 
companies, nongovernmental organizations, and 
nonprofit entities. It is important to address private 
actors’ involvement in light of the aim to achieve 
UHC. For example, private actors may not always 
have the incentives to deal with externalities that 
affect the availability, accessibility, acceptability, 
and quality (AAAQ) of health care services; they 
may not be in a position to provide “public goods”; 
or they may operate under imperfect information. 
In this article, we take a neutral approach toward 
this phenomenon, meaning that we assume that 
private sector involvement is a reality that needs to 
be addressed as appropriately as possible. 
Drawing on existing research and evidence, 
we first discuss some facts and trends regarding the 
role of private actors in the health sector. Subse-
quently, we explore the normative overlaps between 
UHC and the right to health. We then address the 
tripartite relationship between UHC, private sector 
involvement, and the right to health. We explain 
that based on international human rights law, 
states are free to choose any mix of public and pri-
vate involvement in the health sector. Nonetheless, 
they have a legal “obligation to protect,” based on 
which they must protect individuals from harmful 
actions by non-state actors, including those in the 
health sector. This undertaking results in both sub-
stantive and procedural obligations for states, and 
it embraces the state’s duty to ensure the AAAQ 
criteria, regardless of whether health care services 
are publicly or privately provided. In relation to all 
of the above, we stress the importance of effective 
monitoring, accountability, and participatory 
mechanisms.
We identify a human rights impact assessment 
of the consequences of the (further) involvement 
of private actors in the health sector. While most 
obligations identified in this article fall on states, 
there are also several tentative and progressive ob-
ligations for non-state actors in the health sector. 
However, given that such actors do not have formal 
legal obligations (for human rights treaties such as 
the International Covenant on Economic, Social 
and Cultural Rights are aimed at states), an explo-
ration of these potential obligations falls outside of 
the scope of this article.
Private sector involvement: Definition, 
trends, and challenges
Definition
Private sector participation in health care is not 
a new phenomenon. To the contrary, public and 
governmental concern in health care appears to 
have come to the fore only relatively recently.2 
This is certainly the case with respect to health 
care financing.3 The involvement of private actors 
in the provision of health care—whether as direct 
providers of services (e.g., physicians, pharmacies, 
and hospitals) or as the providers or manufacturers 
of materials and technologies used in health care 
provision—has a long history. 
There is no concrete legal definition of private 
sector participation, and it appears that related 
concepts, such as public-private partnerships and 
privatization, are used inconsistently.4 It is there-
fore somewhat challenging to precisely define 
private sector involvement in health care. Given 
that it is not a passive concept but an actual state of 
affairs, it seems more reasonable to describe what 
private sector participation in health care may en-
tail. Such involvement encompasses participation 
in the health care sector and would thus cover a 
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complex range of activities performed by various 
types of non-state actors in the health sector.5 These 
actors include (multi)national corporations, non-
governmental organizations, private institutions 
(including charitable bodies and other nonprofit 
entities), and private individuals, such as general 
practitioners and consultants. Their roles and ac-
tivities may include the direct provision of health 
care, the management of health care institutions, 
the manufacturing of health care goods and ser-
vices (e.g., medicines, pharmaceutical products, 
and rehabilitation), and the financing of health 
care products and services. These roles and activ-
ities may also be carried out within a publicly run 
health care system. This is the case in the United 
Kingdom, where private actors have a role in nurs-
ing homes for persons with disabilities under the 
National Health System.6 They may also take place 
through public-private partnerships, or in privat-
ized contexts (as discussed below).7 
Given the multitude of potential roles and 
players in the health care sector, this article will 
focus on only a few of them—the ones we con-
sider to pose relevant challenges with respect to 
the realization and implementation of the right 
to health. Thus, our focus will be on the role of 
(multi)national companies, nongovernmental or-
ganizations, and nonprofit entities involved in the 
direct provision of health care, the supply of health 
care related goods, and health care financing (see 
Table 1). These roles may be the result of historical 
developments (e.g., private actors already operating 
in health care provision prior to the introduction 
of a public health care system), privatization, or an 
increased reliance on public-private relationships. 
Here it is also important to acknowledge the role of 
nongovernmental organizations, such as Médicins 
Sans Frontièrs and religious organizations, in pro-
viding health care services within the development 
or humanitarian contexts in situations in which 
states are incapable of or unwilling to provide those 
services. Due to space constraints, however, we will 
not discuss those contexts here.
For this article, we consider privatization to 
entail the transfer of the direct provision of health 
care services or health care financing from public 
authorities to private actors. This description is 
based on the definition of privatization provided 
by the Committee of Ministers of the Council of 
Europe, which defines it as 
i. the total or partial transfer from public ownership 
or control of a public undertaking so that it ceases to 
be a public undertaking; ii. the transfer to a private 
person of an activity previously carried on by a pub-
lic undertaking or public authority, whether or not 
accompanied by a transfer of property.8 
There are mixed experiences with privatization 
from the perspective of the realization of the 
right to health. In the Netherlands, where a single 
compulsory health insurance scheme has replaced 
the dual system of public and private insurance, 
the now private health insurance companies are 
obligated to accept every resident in their area of 
activity and to provide a basic health insurance 
package that has been designed by the government.9 
While this transition has been moderately positive, 
in other countries the experience is less so. China, 
for example, has had to overcome difficulties as a 
result of its transition to a market economy. In 1984, 
it reduced the government’s role in the health sec-
tor, which caused many health care professionals to 
lose their public subsidies, while the government 
exerted little control over the behavior of health 
care organizations.10 Many health care workers be-
came “private entrepreneurs,” and the vast majority 
of the population remained uninsured. Because of 
these problems, in 2009 the government decided 
to abandon a market-led health care system and 
launched a new round of health care reform.11 By 
2011, a government-subsidized insurance system 
provided modest health coverage to 95% of the 
population, and an effort to create a primary care 
system was introduced.12
Public-private partnerships in health care, 
which are distinct from privatization, are another 
way in which private sector participation can take 
place. As with privatization, there is no single legal 
definition of public-private partnerships. The World 
Health Organization (WHO) and its Legal Counsel 
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describe these partnerships as covering a “wide vari-
ety of ventures involving a diversity of arrangements, 
varying with regard to participants, legal status, gov-
ernance, management, policy-setting prerogatives, 
contributions, and operational roles.”13
Trends and challenges 
Given that private sector participation in health 
care takes many shapes and involves various kinds 
of actors, the academic literature on the subject is 
not conclusive as to whether this participation has 
a positive or negative impact.14 There seems to be 
an increasing reliance on private actors to provide, 
finance, and supply health care goods and services. 
In Africa, for example, the International Finance 
Corporation has found that “the private sector 
already delivers about half of Africa’s health prod-
ucts and services.”15 There are various reasons for 
this: the perceived lack of inefficiency and quality 
in the provision of public health care, increased 
costs and reduced budgets for health care due to 
the 2007–2008 financial crisis, and encouragement 
by international financial institutions to rely on 
private actors to decrease the burden on national 
budgets.16
Some recent studies suggest positive outcomes 
in terms of private sector participation. For exam-
ple, with respect to access to health care facilities 
for childbirth and the treatment of acute respirato-
ry illness, private sector participation in a number 
of sub-Saharan African countries appears to have 
led to improved performance in terms of access 
and equity.17 However, that particular study notes 
that its findings were limited since it was unable to 
measure two very relevant aspects related to health 
care and the right to health: how much did individ-
uals have to pay to access these facilities, and what 
was the quality of the care provided?18 Other studies 
are more cautious and cannot find overwhelming 
evidence in favor of or against increased private 
sector participation.19 Nonetheless, in health care,20 
there is no consistent manner for measuring the 
contribution of private actors. In some cases, pri-
vate sector participation has led to increased costs 
for patients—for example, through higher out-of-
pocket expenses when governments do not cover 
these costs through subsidies or taxes, or through 
public insurance coverage—and not necessarily 
to a more efficient provision of health care.21 Weak 
regulatory frameworks appear to be an important 
problem in this regard.22
In terms of the private sector’s involvement in 
promoting UHC, there is a lot of discussion on what 
precisely this sector can contribute, given the vary-
ing functions it can perform.23 On the one hand, we 
should recognize that the private sector may be bet-
ter placed than the government to deliver certain 
services and that it is able to make a contribution to 
health financing. On the other, there is an urgency 
to uphold the state’s ultimate responsibility for the 
health of its citizens. Our human rights analysis 
below offers some suggestions in this regard.
Conceptual overlap between universal health 
coverage and the right to health
The goal of UHC is to “ensure that all people obtain 
the health services they need without suffering 
financial hardship when paying for them.”24 Ac-
cording to WHO, UHC is a “practical expression 
of the concern for health equity and the right to 
health.”25 This leads us to ask how UHC and the 
right to health are connected. An identification 
of the various components of UHC, on the one 
hand, and the right-to-health framework, on the 
other, reveals many dense connections between 
the two.26 For example, while affordability is a key 
components of the right to health, it also underpins 
UHC.27 In addition, the inclusion of a specific tar-
get related to UHC in the Sustainable Development 
Goals, which emphasizes the provision of quality 
UHC that is also financially accessible, reinforces 
the link between UHC and the right to health.28 
Table 2 maps a number of key components of UHC 
and shows their connection to the right-to-health 
framework.
Private sector involvement and the right to 
health
The state’s “obligation to protect” and the AAAQ
Based on the right to health as framed under in-
ternational and domestic law, states are obliged to 
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ensure timely access to good-quality care for their 
residents.30 Governments, as the primary duty 
bearers, have a responsibility to ensure that health 
care services (even if privately provided) are avail-
able, accessible, acceptable, and of good quality. 
They must ensure that mechanisms are in place for 
patients to seek legal redress if they have received 
inadequate or untimely care. These obligations do 
not necessarily mean that the state must be the 
actual provider of health care or that it must main-
tain a public health system. General Comment No. 
3 of the United Nations Committee on Economic, 
Social and Cultural Rights, adopted in 1990, states 
that “the undertaking ‘to take steps ... by all appro-
priate means including particularly the adoption of 
legislative measures’ neither requires nor precludes 
any particular form of government or economic 
system” (emphasis added).31 And it concludes that 
“the Covenant is neutral and … the rights recog-
nized in the Covenant are susceptible of realization 
within the context of a wide variety of economic and 
political systems” (emphasis added.)32 This indicates 
Type of involvement Actors
Payers or financers Private health insurance companies
Charities
Providers Private hospitals and clinics




Suppliers of medical equipment
Table 1. Forms of private sector involvement
Universal health coverage: Factors that must be in place29 Obligations of the right to health (General Comment No. 14)
A strong, efficient, well-run health system that meets priority health 
needs through people-centered integrated care, implying the following:
Adoption and implementation of a national public health strategy and 
plan of action as a core obligation (General Comment No. 14, para. 
43(f))
Informing and encouraging people to stay healthy and prevent illness Information accessibility (General Comment No. 14, para. 12)
Detecting health conditions early Prevention (International Covenant on Economic, Social and Cultural 
Rights, arts. 12(2)(b) and (c))
Having the capacity to treat disease Treatment (International Covenant on Economic, Social and Cultural 
Rights, arts. 12(2)(c) and (d))
Helping patients with rehabilitation
A system for financing health services so people do not suffer financial 
hardship when using them
Affordability (“financial accessibility”) (General Comment No. 14, 
para. 12)
Access to essential medicines and technologies to diagnose and treat 
medical problems
Access to essential medicines as a core obligation (General Comment 
No. 14, para. 43)
A sufficient capacity of well-trained, motivated health workers who can 
provide the services based on the best available evidence
Training of health personnel as a core obligation (General Comment 
No. 14, para. 44(e))
Coverage of all components of the health system: service delivery 
systems, workforce, facilities and communication networks, 
technologies, information systems, quality assurance mechanisms, 
governance, and legislation
Availability, accessibility, and high quality of health services (General 
Comment No. 14, para. 12)
A progressive expansion of coverage of health services and financial 
risk protection as more resources become available
Progressive realization (International Covenant on Economic, Social 
and Cultural Rights, art. 2(1); General Comment No. 3)
Not necessarily free coverage for all possible health interventions The right to health is “not a right to be healthy” (General Comment 
No. 14, para. 8); affordability means making health services financially 
accessible, not free of charge (General Comment No. 14, para. 12) 
Steps toward equity, development priorities, social inclusion, and 
cohesion
Importance of the underlying determinants of health (General 
Comment No. 14, para. 4)
Table 2. Normative overlaps between universal health coverage and the right to health 
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that based on the right-to-health framework, gov-
ernments are free to choose any mix of public and 
private involvement in the health sector that they 
consider suitable. 
According to the World Bank’s 2004 World 
Development Report, governments may not neces-
sarily play the role of direct provider of health care 
services; however, the possibility of market failure 
calls for governments to play a role in financing, 
regulation, and information dissemination.33 In this 
light, it is necessary to identify the most relevant 
legal obligations pertaining to the right to health as 
they relate to the involvement of the private sector. 
These obligations apply to states regardless of the 
type or organization of their health care system, 
and they mean that states must ensure that all ac-
tors in the health sector, whether public or private, 
respect the right to health.34 
Human rights treaties impose three levels 
of legal obligations on states: the obligations to 
respect, to protect, and to fulfill. The obligation to 
respect requires states to refrain from interfering 
directly or indirectly with the enjoyment of the 
right to health; the obligation to protect requires 
states to take measures that prevent third parties 
from interfering with guarantees under the right to 
health; and the obligation to fulfill requires states to 
adopt appropriate measures toward the full realiza-
tion of the right to health.35 The obligation to protect 
is of particular significance in this context since it 
requires active monitoring of the activities of third 
parties. When certain services fall into private 
hands, there is a shift from the state “respecting” 
and “fulfilling” the right to a state’s obligation to 
“protect.”36 The state is no longer the provider of the 
service, but now needs to oversee third parties to 
ensure that they provide this service in an adequate 
fashion in conformity with the AAAQ framework. 
The obligation to protect has also been em-
phasized by international courts. For example, the 
Inter-American Court of Human Rights singled 
it out in Ximenes-Lopes v. Brazil, which concerned 
the regulation of a private psychiatric clinic in 
Brazil that participated in the public health scheme 
set up by the government.37 The court asserted that 
under the American Convention on Human Rights, 
international liability comprises acts performed by 
private entities acting in a state capacity. In this con-
text, the court referred to the Brazilian Constitution, 
which recognizes that health care is open to private 
actors but also identifies the state’s duty to regulate, 
supervise, and control health programs and ser-
vices, whether carried out directly or through third 
parties.38 The court found that 
States must regulate and supervise all activities 
related to the health care given to the individuals 
under the jurisdiction thereof, as a special duty to 
protect life and personal integrity, regardless of the 
public or private nature of the entity giving such 
health care.39 (emphasis added) 
The obligation to protect falls into a number of in-
terlinked duties on the part of the state.40 It entails 
four key components: the obligation to regulate all 
actors in the health sector through the adoption of 
legislation, regulations, and policies; the obligation 
to monitor, through independent mechanisms, the 
behavior of these actors; the obligation to ensure 
that there is accountability for violations commit-
ted by public and private actors; and the obligation 
to ensure the population’s participation in health 
care decision-making.41
As observed above, the state’s obligation to 
protect is closely connected to regulation and the 
AAAQ criteria. As stated in General Comment No. 
14, this obligation requires the state to guarantee 
that private actor involvement in the health sector 
(referred to as “privatization”) does not negatively 
affect the AAAQ: 
[T]o ensure that privatization of the health sector 
does not constitute a threat to the availability, 
accessibility, acceptability and quality of health 
facilities, goods and services … States should also 
ensure that third parties do not limit people’s access 
to health-related information and services.42 
When it comes to private actor involvement, the 
question must be addressed whether this involve-
ment negatively affects enjoyment of the AAAQ. 
For example, in terms of geographic accessibility, 
the operation of private hospitals should not mean 
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that health services are available only in affluent 
areas. Table 3 defines a set of questions that can be 
asked when determining how private actors might 
be affecting the AAAQ criteria (which also apply to 
all public actors in the health sector): 
Regulation of the private sector as an element of 
the obligation to protect
As mentioned, regulation is a key tool for dealing 
with the conduct of actors operating in the health 
care arena, and it may take various forms, depend-
ing on the desired goals.43 One author’s definition of 
regulation, which we like due to its resemblance to 
what the obligation to protect requires in the context 
of UHC, describes it as “the sustained and focused 
attempt to alter the behavior of others according 
to defined standards or purposes with the inten-
tion of producing a broadly identified outcome or 
outcomes, which may involve mechanisms of stan-
dard-setting, information gathering and behavior 
modification.”44 According to the literature on the 
subject, many of the rationales for regulation can be 
ascribed to instances of “market failure”45—that is, 
situations in which “[m]arket imperfections make it 
impossible for market forces to achieve an efficient 
allocation of resources.”46 Since regulation is adopt-
ed for various reasons, including compensating for 
market failure, for the purposes of this article, we 
will briefly mention two general types of regula-
tion: economic regulation and social regulation.47 
Economic regulation deals with the regulation of 
monopoly and competition. Social regulation, on 
the other hand, is concerned with the promotion of 
social objectives. Christopher Foster provides some 
examples of objectives that may be served by social 
regulation, including achieving fairness between 
various interest groups, redistributing income, and 
providing a service deemed important by the gov-
ernment, such as health care.48 For our purposes, it 
is precisely social regulation that may be of interest 
in relation to the human rights obligation to protect 
in the context of health care. 
As stated in the definition above, regulation 
encompasses a “sustained and focused attempt to 
alter the behavior of others.” Arguably, a proper 
realization of the obligation to protect also requires 
a sustained effort by the state to alter or guide the 
behavior of private entities involved in the health 
care sector in order to protect human rights, which 
is one of the main outcomes of social regulation. 
Availability
Is the availability of goods, services, and personnel ensured in the health system, despite the involvement of private actors?
Accessibility
Non-discrimination Are sufficient health services available to secure the needs of vulnerable populations?
Do private actors provide the services in such a manner that they are equally accessible, taking into account the 
needs of vulnerable populations?
Physical accessibility Does the involvement of private actors affect the geographic accessibility of health care services?
Affordability Does private sector involvement make the health care more expensive, either when paid with public funding or 
by citizens? 
Does private sector involvement lead to increased out-of-pocket expenditures? 
Informational accessibility Does private actor involvement affect patients’ ability to make informed choices? 
Are patients sufficiently informed about the quality and conditions of their private care?
Acceptability
Is the private care respectful of medical ethics and culturally appropriate (respectful of the cultures of individuals, minorities, peoples, and 
communities)?
Is the private care sensitive to gender and life-cycle requirements, as well as designed to respect confidentiality and improve the health status of 
those concerned?
Does the private health insurance accept all patients, or does it select them on the basis of their health or financial status?
Quality
Do private health facilities guarantee a certain quality of care?
Do practitioners who work in private health clinics receive proper training?
Table 3. The AAAQ and the role of the private sector in health care
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This requires the fulfillment of certain substantive, 
institutional, and procedural elements to make 
social regulation usable as a tool for the implemen-
tation of the right to health.49 
Substantive elements of regulation
Regulatory measures that aim to steer or alter the 
behavior of private actors operating in this sector 
should embody the AAAQ framework (see Table 3 
above). Thus, with respect to availability, if the state 
is going to increasingly rely on private actors to pro-
vide health care services, regulations should ensure 
that there are sufficient numbers of providers in the 
geographical areas where they operate. Regulations 
should also ensure that private actors do not retreat 
from particular areas just because they are not, or 
no longer, financially rewarding. 
With regard to accessibility, regulations must 
guarantee non-discriminating access to private 
health care facilities. They must further ensure 
that health care is physically accessible—in other 
words, that health care facilities are within safe 
physical reach for all sections of the population. 
Financial accessibility is also a matter that should 
be subjected to regulation—for example (and this 
is related to the issue of financing), by ensuring 
that private insurance companies offer affordable 
policies or by providing subsidies to people who 
would otherwise be unable to obtain indispensable 
treatment that may be offered by private clinics. 
When it comes to substantive regulation of the pri-
vate health insurance market, for example, Neelam 
Sekhri et al. mention the need for a robust regula-
tory framework, especially in developing countries 
where private coverage may be the only form of 
financial protection available to the population.50 
The authors refer to some countries’ practice of 
conscripting private insurance to serve the public 
goal of equitable access.51 However, they also stress 
that regulation should not be so restrictive that it 
“strangle[s] the market.”52 
Substantive regulation also plays a role in se-
curing the acceptability and quality of health care 
services provided by private actors. Regulations 
dealing with medical ethics should be present for 
both private and public health care providers. Regu-
lations should also require private actors to provide 
services that are mindful of the different cultures of 
their patients. National regulatory measures must 
also aim to ensure that private and public health 
care providers alike abide by the necessary quality 
requirements and that their personnel have the re-
quired training and certificates.
Arguably, these concerns about substantive 
regulation also apply to nonprofit organizations. 
Nongovernmental organizations have increasingly 
been involved in the delivery of health care, espe-
cially in developing countries. Lucy Gilson et al. 
argue that there should be a strong government 
presence in coordinating and regulating health 
care provision by these actors.53 
Institutional and procedural elements of 
regulation
Institutional and procedural regulation entail reg-
ulatory bodies and procedural rules that allow the 
state to control and monitor the activities of private 
actors in the health care sector, thus helping it alter 
their conduct. This type of regulation requires the 
establishment of independent regulatory bodies 
and a venue where those affected by the conduct 
of health care providers can seek redress.54 The 
latter usually includes courts of law, where victims 
can bring claims against the providers. Given that 
human rights obligations, as they currently stand, 
do not directly apply to non-state actors, having an 
effective avenue for seeking redress for the harmful 
effects of conduct committed by private entities is 
of great importance.
Insofar as these regulatory efforts relate to the 
provision and financing of health care, as well as 
the manufacturing of health care goods, they must 
strike a balance between, on the one hand, ensur-
ing the economic efficiency of services and the 
production of these goods and, on the other, ensur-
ing the protection of the right to health.55 A World 
Bank study has identified a number of institutional 
criteria based on the findings of several studies in 
order to assess the effectiveness of regulation and 
regulators for privatized infrastructure and essen-
tial services.56 Arguably, the same approach can be 
used for the institutional and procedural regulation 
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of private sector participation in health care. First, 
regulation must be coherent, entailing agreement 
between the different laws guiding regulation and 
the elimination of inconsistencies. Coherence with 
regard to regulators aims at ensuring that the latter 
have clearly defined responsibilities, and it should 
require them to publish their goals and reasons for 
adopting decisions. 
Second, effective institutional and procedural 
regulation requires the regulatory body to be free 
from political influence; this can be achieved, for 
example, by establishing a statutory basis for the 
regulator, free from any ministerial control. It 
also requires the appointment of regulatory bod-
ies on the basis of professional criteria through 
open processes involving the participation of 
key stakeholders, such as health care consumers 
and patients. Additionally, in order to maintain a 
regulatory body’s independence, the central gov-
ernment should not be able to easily overturn its 
decisions. Equally, private sector entities involved 
should not be able to influence the regulator or its 
decisions. Third, the regulator must be accountable. 
Stakeholders should be able to question the reason-
ing behind the regulator’s decisions, and the latter 
should be subject to review by courts and other in-
dependent, nonpolitical bodies. Inspiration for the 
creation of independent regulatory bodies in the 
health care sector could be drawn from the Paris 
Principles on national human rights institutions.57
Obliging the regulator to publish an annual 
report documenting its activities can also contrib-
ute to its accountability, help monitor its efficiency, 
and guard against corruption. Fourth, transparen-
cy is essential for the effective work of the regulator. 
Its regulatory rules and decisions need to be made 
public and accessible to all actors with a vested 
interest: health care providers, financers, the pro-
ducers of health care goods, and patients. Fifth, 
the regulator needs to be predictable. This means 
following the rule of law and basing its decisions on 
durable rules and procedures. Finally, the regulato-
ry body should be endowed with sufficient financial 
resources, and its personnel must have relevant 
expertise.58 Having stated this, it is important to 
recognize the difficulties in establishing a proper 
regulatory framework in practice. Low-income 
countries with varying degrees of development and 
respect for the rule of law may face challenges in 
coming up with proper independent and effective 
regulatory bodies and procedural regulations. The 
following section dedicates more attention to the 
operationalization of such regulation.
Operationalizing the obligation to protect 
through monitoring, accountability, and 
participation
Monitoring, which is closely connected to insti-
tutional regulation and accountability, means 
consistently analyzing and overseeing the process 
of realizing health-related rights. Monitoring can be 
done both by the state (through independent regu-
latory bodies and health care inspectorates) and by 
civil society organizations. The aim of monitoring 
is to obtain the information that governments need 
to track their progress toward health-related targets. 
Quite often, governments and civil society organiza-
tions use indicators to measure this progress.59 
Given the connection between monitoring 
and institutional regulation, some observations 
and developments are worth mentioning. A recent 
trend under international human rights law in-
volves the creation of mandatory national bodies 
designed to monitor the implementation of human 
rights treaty obligations. One example includes the 
national preventive mechanisms (NPMs) that states 
must establish under the Optional Protocol to the 
Convention against Torture. These mechanisms are 
charged with conducting inspections of detention 
facilities, including psychiatric institutions and 
hospital wards in which persons are deprived of 
their liberty. Another example can be seen in the 
national framework mechanisms that states have 
to establish under the Convention on the Rights of 
Persons with Disabilities, which are of great interest 
to our discussion: states must maintain, strengthen, 
designate, or establish “a framework, including one 
or more independent mechanisms, as appropriate, 
to promote, protect and monitor implementation” 
of the disabilities convention.60 These bodies, 
whether already existing or newly created, are 
charged with monitoring how states abide by their 
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obligations under this treaty. Arguably, they can 
fulfill a role in monitoring the conduct of private 
sector participants in health care. 
Again, it is important to acknowledge the 
difficulty of guaranteeing independent, transpar-
ent, and effective regulatory bodies, particularly 
in low-income countries. At the same time, there 
are ways to strengthen and improve states’ insti-
tutional frameworks to face these challenges. For 
example, the United Nations Subcommittee on the 
Prevention of Torture, the international superviso-
ry body established under the Optional Protocol 
to the Convention against Torture to complement 
the work of the NPMs, has taken upon itself to help 
improve NPMs’ mandates, working methods, and 
awareness of the importance of independence and 
transparency by offering consultations, coopera-
tion, and advice.61
Accountability has also been described as 
“the process which requires government to show, 
explain and justify how it has discharged its obli-
gations regarding the right to the highest attainable 
standard of health.”62 While the accountability 
process, to some extent, is about monitoring and 
evaluating the state’s own actions, the responsibil-
ity to provide health care is partly in the hands of 
other actors, such as private health care providers, 
private insurance companies, and pharmaceutical 
companies. In such cases, the state must oversee 
the actions of these actors. Given the complexity 
of health systems, a wide variety of accountability 
mechanisms is required to ensure that the right to 
health is properly overseen. Based on a compre-
hensive overview by Potts, Table 4 distinguishes 
between five different accountability mechanisms 
and provides examples of ones that can be adopted 
for ensuring health sector accountability.63 
The state’s obligations to protect and fulfill 
in relation to public and private health care 
financing 
As observed above, the private sector can also play 
an important role with respect to the financing of 
health care. According to a WHO study, financ-
ing plays a threefold role: (i) raising the required 
resources for health and health care, (ii) removing 
financial barriers to health care and minimizing the 
financial risks implied by illness, and (iii) making 
better use of resources.72 Although the financing of 
health care takes place primarily through taxation, 
private actors also have a role to play. For example, 
with regard to the first task, private companies or 
charities can provide financial support to help run 
the health care system. With respect to the second, 
private insurance companies can be engaged by 
the state to facilitate or complement existing public 
insurance systems. At the same time, however, they 
Nature  Type Examples
Judicial Judicial review by domestic and 
international courts, constitutional 
redress, public interest litigation
Ximena Lopez v. Brazil, a case before the Inter-American Court of Human 
Rights concerning the regulation of private actors
The Treatment Action Campaign case and other right-to-health case law from 
the South African Constitutional Court64
Quasi-judicial Hospital complaint boards, national 
human rights institutions, national 
ombudsmen, regional and international 
human rights treaty bodies
Alyne da Silva Pimentel v. Brazil, a case before the CEDAW Committee 
concerning discrimination against women65
A public inquiry on reproductive health violations initiated by the Kenya 
National Commission on Human Rights66
ERRC v. Bulgaria and other case law from the European Committee of Social 
Rights of the Council of Europe concerning the right to the protection of health 
in the (Revised) European Social Charter67
Administrative Human rights impact assessment by a 
governmental or independent body
Equality and human rights impact assessment carried out by Aberdeen City 
Council68
Political Parliamentary committee review of 
budgetary allocations, health councils and 
committees
Australia’s Human Rights (Parliamentary Scrutiny) Act 201169
Social Domestic and international 
nongovernmental organizations, the 
media, public hearings, social audits
Social audits in Andhra Pradesh, India70
Inclusive public participation in China’s new health care reform71 
Table 4. Five types of accountability
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could also be an obstacle to this aim if, for exam-
ple, their insurance premiums are far above what 
low-income families can afford or if their coverage 
is insufficient for reducing the financial burdens 
incurred by persons using the insurance. Here, 
the obligation to protect plays an important role 
through the duty to regulate the conduct of private 
actors involved in or hindering the proper financ-
ing of health care systems. 
While our focus is on the state’s duty to reg-
ulate private actors in the health sector, closely 
related to this is governments’ responsibility to se-
cure sufficient (public) funding in order to remove 
financial risks and barriers to access.73 Financing 
is also arguably an element of the state’s positive 
obligation to fulfill in terms of a duty to facilitate 
the enjoyment of the right to health. The obligation 
to fulfill is further operationalized when govern-
mental financing is used to directly aid individuals 
who are unable to enjoy the right themselves due to 
economic circumstances. Here, for example, one of 
the state’s roles is to minimize high out-of-pocket 
payments to public and private providers (which 
are regarded as an important reason for the lack of 
proper access to health care) by establishing pre-
paid and pooling systems of financing.74 This would 
also enhance UHC, which, according to WHO, 
is most closely achieved through “current pooled 
funds.”75 Of course, this may depend on an efficient 
taxation system that helps bolster public finances 
to feed these funds. A failure to provide adequate 
financing to health care would imply a violation of 
the right to health under the International Cove-
nant on Economic, Social and Cultural Rights.
A right-to-health impact assessment for 
private sector involvement in the health 
sector
How can the state ensure that private actors in 
the health sector take the AAAQ framework into 
account? Several authors have suggested that states 
should conduct human rights impact assessments 
prior to the introduction of private sector in-
volvement.76 These assessments enable states and 
international and national organizations to assess 
the possible human rights implications of a certain 
policy, trend, or development. They are increas-
ingly being used in the context of privatization, 
new business plans, and trade agreements.77 For 
example, Paul Hunt, the former United Nations 
Special Rapporteur on the right to health, has 
suggested undertaking a human rights impact as-
sessment of trade-related policies. He argues that 
such assessments should be conducted at both the 
international and national level.78 With regard to 
health care privatization, he notes that it “should be 
preceded by an independent, objective and publicly 
available assessment of the impact on the respective 
right.”79 
Drawing from Simon Walker’s study on 
human rights impact assessments for trade agree-
ments, which in turn is partially inspired by Hunt’s 
work, we recommend the following steps in order 
to assess the impact of private sector involvement 
on the right to health in a given country:80
• Step 1 – Identify the relevant legal, economic, 
social, and regulatory contexts with regard to the 
right to health; identify the people who will most 
likely be affected by private sector involvement 
in health care provision, health care financing, 
or UHC (e.g., patients in general, vulnerable 
groups, doctors, medical researchers, providers 
of ambulance services); and inventory the avail-
able goods and services within the health system, 
including those provided by the private sector.
• Step 2 – Narrow down the various manifestations 
of private sector involvement in health care and 
UHC that could have the most significant impact 
on the enjoyment of the right to health care in 
terms of availability, accessibility, acceptability, 
and quality.
• Step 3 – Determine the scope of the assessment 
by identifying different/future scenarios of pri-
vate sector participation in the measures to be 
assessed, and identify the relevant indicators and 
stakeholders to be consulted.81 In the context of 
low-income countries, seek international assis-
tance to address the scope of the assessment and 
the identification of indicators and stakeholders 
to be consulted.
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• Step 4 – Collect and analyze data to verify the 
potential impact of private sector involvement 
in health care and UHC; evaluate the results 
and determine which of the already identified 
stakeholders are the most likely to be affected 
by it; determine whether the accessibility of 
health care is compromised (Does private sector 
involvement private sector involvement result 
in discrimination? Do they maintain a certain 
affordability in health care?).
• Step 5 – Recommend measures that would lead 
to or enhance the positive impacts of private sec-
tor participation, as well as measures to reduce, 
ameliorate, or eliminate negative impacts, taking 
care to consider the acceptability and quality 
elements of the AAAQ framework.
• Step 6 – Evaluate the general assessment to see 
if the objectives of the assessment have been 
met and to examine the extent to which the 
stakeholders have been consulted. According to 
Walker,82 at this stage, a monitoring plan should 
be adopted in consultation with those stakehold-
ers to keep an eye on actual impacts once the 
measures regarding private sector involvement 
in health care, financing, and UHC have been 
adopted. Arguably, this monitoring plan should 
consider the AAAQ framework.
• Step 7 – Compile and adopt a report of the assess-
ment that includes an overview of the preceding 
steps. 
Conclusion
The aim of UHC—which is closely connected to 
the right to health—is for everyone to have access 
to a full range of good-quality and affordable 
health services. Countries around the globe have 
had mixed experiences with regard to private actor 
involvement in the health sector. The consequenc-
es of such involvement should be monitored very 
carefully. 
Human rights law does not interfere with 
the state’s choice of its health care system—that is, 
whether it is public, private, or mixed. However, it 
provides an authoritative set of legal tools for assess-
ing the consequences of private sector involvement. 
Based on human rights law, governments have an 
obligation “to protect” the right to health. This 
means a duty to adopt regulations and other mea-
sures to regulate all actors in the health sector. Such 
regulation should reflect the state’s duty to ensure 
that health services are available, accessible, accept-
able, and of good quality. As we have suggested in 
this article, governments can be encouraged to con-
duct human rights impact assessments to assess the 
consequences of privatization prior to its introduc-
tion. We have also briefly asserted that states’ duty 
to fulfill entails, among other things, an obligation 
to secure the financing of their health system, such 
as through taxation and in collaboration with the 
private sector.
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